Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2010

Mar 5, 2010

34519_dirs_2010-03-05_111b276c-f81c-466d-bfb8-8b1e71f4b729.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2010-03-03

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-03-03 Common Stock, par value $0.10 per share P 1000 $3.7928 Acquired 458881 Direct

Footnotes

F1: This figure includes 189,737 shares of common stock held by Arterio, Inc., a company owned solely by Mr. Rothschild.